...
首页> 外文期刊>Obstetrical and gynecological survey >Low-Molecular-Weight Heparin and Recurrent Placenta-Mediated Pregnancy Complications: A Meta-analysis of Individual Patient Data From Randomised Controlled Trials
【24h】

Low-Molecular-Weight Heparin and Recurrent Placenta-Mediated Pregnancy Complications: A Meta-analysis of Individual Patient Data From Randomised Controlled Trials

机译:低分子量肝素和复发性胎盘介导的妊娠并发症:来自随机对照试验的个体患者数据的META分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Placenta-mediated pregnancy complications include pre-eclampsia, birth of a small-for-gestational-age neonate, placental abruption, or late pregnancy loss and lead to maternal and fetal or neonatal morbidity and mortality. These complications have a high risk of recurring in subsequent pregnancies, and effective preventive measures are lacking. Findings from some randomized controlled trials suggest that low-molecular-weight heparin (LMWH) can be used to prevent recurrent placentamediated pregnancy complications, but these findings have not been universal.
机译:胎儿介导的妊娠并发症包括预先普利坦斯患者,胎儿患者的诞生,胎盘突然或晚期妊娠损失,导致母体和胎儿或新生儿发病率和死亡率。 这些并发症具有较高的后续怀孕风险,并且缺乏有效的预防措施。 一些随机对照试验的结果表明,低分子量肝素(LMWH)可用于防止复发性胎盘症的妊娠并发症,但这些发现并非普遍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号